Vol 1 No 2 (2021): September – Desember

The second issue follows two threads: that cheap, routinely collected numbers often carry prognostic weight, and that cancer increasingly has to be managed as a chronic disease.

A cohort of 450 nasopharyngeal carcinoma patients at Dr. Sardjito Hospital, Yogyakarta, is used to test whether the peripheral neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios — two numbers already sitting on every full blood count — carry survival information. A second study turns upstream, asking why young smokers take up electronic cigarettes, and how an industry that markets them as the alternative to smoking shapes that decision.

Two case reports trace the long shadow of adjuvant endocrine therapy: a late relapse in hormone-receptor-positive, HER2-negative early breast cancer, and an endometrial cancer arising after tamoxifen-containing adjuvant treatment. A closing review reads lung cancer — Indonesia's third most common cancer after breast and cervical — through the paradigm of chronic disease rather than terminal illness.